Response to Different Wheat Genotypes in Not-celiac Wheat Sensitivity
Launched by UNIVERSITY OF PALERMO · Jan 16, 2017
Trial Information
Current as of August 31, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how different types of wheat affect people with non-celiac wheat sensitivity (NCWS), a condition where certain wheat components, not just gluten, can cause digestive and other symptoms. Researchers want to find out if ancient types of wheat are easier for patients to tolerate compared to modern varieties, and they will study specific proteins in wheat that may trigger symptoms. By understanding these differences, the goal is to provide clearer guidance for people experiencing NCWS.
To participate in this study, individuals must be between 18 and 75 years old and have been diagnosed with NCWS based on specific criteria, like having negative tests for celiac disease and wheat allergies. Participants will be closely monitored for their reactions to different wheat types and will undergo tests to see how their bodies respond to the proteins in these wheats. This study aims to give better insights into managing wheat sensitivity and improving dietary choices for those affected.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- All the patients will meet the recently proposed criteria:
- • negative serum anti-tissue transglutaminase and antiendomysium (EmA) immunoglobulin (Ig)A and IgG antibodies
- • absence of intestinal villous atrophy
- • IgE-mediated immunoallergic tests negative to wheat (skin prick tests and/or serum specific IgE detection)
- • follow-up duration \>12 months after the initial diagnosis
- • at least two outpatient visits during the follow-up period.
- Adjunctive criteria adopted in our patients will be:
- • resolution of the gastrointestinal symptoms on a standard elimination diet, without wheat, cow's milk, egg, tomato, chocolate, or other food(s) causing self-reported symptoms
- • symptom reappearance on DBPC wheat challenge, performed as described previously. As in previous studies, DBPC cow's milk protein challenge and other "open" food challenges will be also performed.
- Exclusion Criteria:
- Exclusion criteria will be:
- • age \<18 years
- • positive EmA in the culture medium of the duodenal biopsies, even if the villi to crypts ratio in the duodenal mucosa was normal
- • self-exclusion of wheat from the diet and refusal to reintroduce it before entering the study
- • other organic gastrointestinal diseases (i.e. careful exclusion of Crohn's disease)
- • concomitant treatment with steroids and/or antihistamines.
About University Of Palermo
The University of Palermo, a distinguished institution located in Italy, is dedicated to advancing medical research and education through innovative clinical trials. Renowned for its commitment to scientific excellence, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct research that addresses critical healthcare challenges. By fostering collaborations with leading researchers and healthcare professionals, the University of Palermo aims to translate scientific findings into effective therapies, ultimately contributing to improved patient outcomes and public health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sciacca, Agrigento, Italy
Palermo, , Italy
Patients applied
Trial Officials
Antonio Carroccio, PhD
Study Director
University of Palermo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials